Perception Prognosis, Goals of Treatment, and Communication
Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists
1 other identifier
observational
50
1 country
1
Brief Summary
The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 20, 2011
CompletedFirst Posted
Study publicly available on registry
July 25, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJanuary 31, 2017
January 1, 2017
2 years
July 20, 2011
January 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of surveys
1 year
Secondary Outcomes (3)
Patients perceptions of prognosis, goals of care, and communication with providers
1 year
Quality of end of life care
1 year
Survival
1 year
Eligibility Criteria
All patients with a recent diagnosis of advanced gastric, esophageal, pancreatic and hepatobiliary cancer, not being treated with curative intent and receiving their cancer care at Massachusetts General Hospital.
You may qualify if:
- Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent.
- Planning to receive chemotherapy at Massachusetts General Hospital
- Ability to read and respond to questions in English.
You may not qualify if:
- Prior chemotherapy for current stage of disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Temel, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director MGH BMT Survivorship Program
Study Record Dates
First Submitted
July 20, 2011
First Posted
July 25, 2011
Study Start
October 1, 2010
Primary Completion
October 1, 2012
Study Completion
June 1, 2014
Last Updated
January 31, 2017
Record last verified: 2017-01